Literature DB >> 28719464

Nuclear CRX and FOXJ1 Expression Differentiates Non-Germ Cell Pineal Region Tumors and Supports the Ependymal Differentiation of Papillary Tumor of the Pineal Region.

Shannon Coy1, Adrian M Dubuc, Sonika Dahiya, Keith L Ligon, Alexandre Vasiljevic, Sandro Santagata.   

Abstract

Papillary tumor of the pineal region (PTPR) is a neuroepithelial neoplasm first described in 2003. Despite the anatomic association of PTPR with the pineal gland, the features of these tumors resemble those of the ependymal circumventricular subcommissural organ (SCO) of the posterior third ventricle. Given the presumed distinct derivation of PTPR and pineal parenchymal tumors, we hypothesized that expression of lineage-specific transcription factors could distinguish these tumors and provide additional insight into the differentiation of PTPR. A broad series of pineal region samples was reviewed, including 7 benign pineal glands, 4 pineal cysts, 13 pineocytomas, 28 pineal parenchymal tumors of intermediate differentiation, 11 pineoblastomas, and 18 PTPR. All samples were evaluated by immunohistochemistry for expression of CRX, a master transcriptional regulator of photoreceptor differentiation expressed in pineal gland and retina and/or FOXJ1, a master transcriptional regulator of ciliogenesis expressed in normal ependymal cells and ependymal neoplasms. Diffuse nuclear CRX expression is present in 100% of pineal samples. FOXJ1 is negative in all pineal samples. CRX staining is present in 53% of PTPR, though expression is nearly always limited to rare cells. Diffuse nuclear FOXJ1 expression is present in 100% of PTPR. Fetal human SCO diffusely expressed FOXJ1 but was negative for CRX. Immunohistochemistry for FOXJ1 and CRX differentiates non-germ cell pineal region tumors with high sensitivity and specificity, including pineal parenchymal tumors and PTPR. Our findings support the hypothesis that PTPR have ependymal differentiation and are phenotypically more similar to SCO than pineal gland.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28719464     DOI: 10.1097/PAS.0000000000000903

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  4 in total

Review 1.  Pineal parenchymal tumor of intermediate differentiation: a systematic review and contemporary management of 389 cases reported during the last two decades.

Authors:  Hajime Takase; Reo Tanoshima; Navneet Singla; Yoshihiko Nakamura; Tetsuya Yamamoto
Journal:  Neurosurg Rev       Date:  2021-10-20       Impact factor: 3.042

Review 2.  Histopathology and molecular pathology of pediatric pineal parenchymal tumors.

Authors:  Alexandre Vasiljevic
Journal:  Childs Nerv Syst       Date:  2022-08-16       Impact factor: 1.532

3.  Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genes.

Authors:  Norman L Lehman; Nathalie Spassky; Müge Sak; Amy Webb; Cory T Zumbar; Aisulu Usubalieva; Khaled J Alkhateeb; Joseph P McElroy; Kirsteen H Maclean; Paolo Fadda; Tom Liu; Vineela Gangalapudi; Jamie Carver; Zied Abdullaev; Cynthia Timmers; John R Parker; Christopher R Pierson; Bret C Mobley; Murat Gokden; Eyas M Hattab; Timothy Parrett; Ralph X Cooke; Trang D Lehman; Stefan Costinean; Anil Parwani; Brian J Williams; Randy L Jensen; Kenneth Aldape; Akshitkumar M Mistry
Journal:  Nat Commun       Date:  2022-04-19       Impact factor: 17.694

Review 4.  Diagnosis and Treatment of Pineal Region Tumors in Adults: A EURACAN Overview.

Authors:  Giuseppe Lombardi; Pietro Luigi Poliani; Renzo Manara; Moncef Berhouma; Giuseppe Minniti; Emeline Tabouret; Evangelia Razis; Giulia Cerretti; Vittorina Zagonel; Michael Weller; Ahmed Idbaih
Journal:  Cancers (Basel)       Date:  2022-07-27       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.